SCHEMBL26313653

SCHEMBL26313653

CCCN(C(=O)c1cc(Cl)ccc1C#N)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.52
TP53 P04637 2/20 0.45
GPBAR1 Q8TDU6 1/20 0.44
ALDH1A1 P00352 4/20 0.44
CYP3A4 P08684 2/20 0.44
LTB4R2 Q9NPC1 1/20 0.42
HTT P42858 2/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
APAF1 O14727 1/20 0.40
MAPT P10636 1/20 0.40
NOS2 P35228 3/20 0.39
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
LMNA P02545 2/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
POLB P06746 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26313667 0.89 TSHR (0.47) TSHRTP53GPBAR1ALDH1A1CYP3A4
SCHEMBL26313764 0.88 CYP3A4 (0.55) TSHRTP53ALDH1A1CYP3A4HTT
SCHEMBL26313663 0.87 TSHR (0.45) TSHRTP53ALDH1A1CYP3A4LTB4R2
Hydrochloric Acid SCHEMBL25411664 0.87 CYP3A4 (0.57) TSHRTP53ALDH1A1CYP3A4HTT
SCHEMBL26313650 0.86 GPBAR1 (0.43) TSHRTP53GPBAR1ALDH1A1CYP3A4
SCHEMBL25411640 0.85 TSHR (0.44) TSHRTP53ALDH1A1CYP3A4HTT
SCHEMBL25411663 0.83 TSHR (0.45) TSHRTP53ALDH1A1CYP3A4HTT
SCHEMBL25412807 0.83 TSHR (0.42) TSHRTP53ALDH1A1CYP3A4HTT
SCHEMBL26313672 0.82 TSHR (0.43) TSHRTP53GPBAR1ALDH1A1CYP3A4
SCHEMBL26313674 0.82 TSHR (0.43) TSHRTP53ALDH1A1CYP3A4HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286913-A1 INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF Gacter Inc. (US) 2023-09-14 US disclosed
US-20230286913-A1 INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF Gacter Inc. (US) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286913-A1 INHIBITORS OF NITRIC OXIDE SYNTHASES (NOS), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF NOS1, NOS3, NOS2 TSHR 990/4885TP53 15/4885GPBAR1 1592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.